comparemela.com

Latest Breaking News On - Biotech and pharma - Page 20 : comparemela.com

Cal-Maine Foods, Blend Labs, DoubleVerify, Adobe, and More Stock Market Movers

Tesla is recalling 2 million vehicles because of Autopilot control issues, Cal-Maine Foods says a company facility in Kansas recently tested positive for.

Federal reserveWall street wednesdayWall streetArticle normalPoultry farmingComputers consumer electronicsApplications softwareToys gamesTelecommunication servicesTrusts funds financial vehiclesInvestment trustsReal estate investment trustsInsurance brokeringDigital content servicesMultimedia content servicesConsumer goods

Pfizer Stock Falls to 10-Year Low on Guidance Slash Why Wall Street Is Disappointed

Pfizer stock was trading at a 10-year low on Wednesday after the pharmaceutical company revised its 2024 guidance. Its new earnings and revenue projections.

Albert bourlaAdam clarkCourtesy pfizerDow jones marketArticle normalBiotechnology servicesRetail wholesaleHealthcare life sciencesCorporate industrial newsIntellectual property rightsIndustrial property rightsBiotech and pharmaNorth americaRapid responseM amp aSeagen inc

Vertex Stock Is Jumping as Data Raise Hope for a Pain Pill Blockbuster

Vertex disclosed promising test results for a drug that could offer an alternative to opioids.

Michael yeeJosh nathan kazisReshma kewalramaniViatris lyricaChristopher raymondStuart arbuckleRaymond jamesVertex oxford lab courtesy pharmaceuticals incorporatedVertex oxford labCourtesy vertex pharmaceuticals incorporatedWall streetArticle normalHealthcare life sciencesSpecialized drugs medicationsNew products servicesResearch development

Johnson & Johnson Earnings to Be Hit by Loss of Stelara Exclusivity, Wells Fargo Says

Wells Fargo downgrades shares of Johnson & Johnson to Equal Weight from Overweight.

Larry biegelsenMark ralstonJoaquin duatoAngela palumboWells fargoGetty imagesEqual weightArticle normalHealthcare life sciencesFinancial performanceAnalysts amp 39 comments recommendationsCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filter

AstraZeneca Reaches Deal to Buy Icosavax The Vaccine Stock Soars 47%

AstraZeneca agreed to acquire respiratory vaccine developer Icosavax in a cash deal expected to close in the first quarter of next year.

Jack dentonIskra reicGetty imagesCerevel therapeuticsArticle normalBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsFinancial performanceShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsAcquisitions mergersCorporate actionsCorporate industrial newsPolitical general news

vimarsana © 2020. All Rights Reserved.